- Before
- Owns 38 agreements and 8 active partners, and too often learns of a milestone from the partner's invoice or the next JSC.
- Now
- Opens the network to see which lines are flagged, reads the six tests behind a milestone and confirms it the day after the first dose.
One Phase 3 first dose, from trial-system event to signed notice
Northwind Bio in-licensed Talmirex (QTX-208) from Quillon Therapeutics in June 2023. On Oct 5, 2026, subject 114-001 is dosed at site 114 in Lyon in TLX-301, the pivotal Phase 3 study. Here is what happens next, screen by screen, in the working solution.
- 01Oct 7
The whole alliance book as one network
Dana Okafor · Alliance directorDana's home screen draws Northwind Bio and its 8 active partners: 38 agreements, 612 obligations, 37 open lines. Each line is one obligation drawn from the clause in force, coloured by kind — milestones, payments, diligence and supply, notices and reports, committees, consents and rights. Three lines are marked: “$40M · flagged” on Quillon, “No consent on file” on Marrow Point and “$15M option · Nov 18” on Brightwater.
Line inspector: “Milestone 4 · Initiation of the first Phase 3 Clinical Trial · $40,000,000 · Due Oct 20 · Clause in force §7.2(d) · as amended by Amendment No. 1 §2.”
- 02Replay · Oct 6, 16:20
A trial-system event, read against every clause
Signal watcherTrial system event 88214 arrives, confirmed by the public registry: first dose in TLX-301, subject 114-001, Lyon, Oct 5. The signal watcher searches 612 obligations and matches 4 clauses in the Quillon licence — §7.2(d), §7.4, §7.6 and §5.2(b). Replaying the match shows each step light in turn: event read, clauses matched, definitions tested, amendment applied, milestone flagged.
“Oct 6 · 16:20 · 4 min, event to tested trigger.”
- 03Last 14 days
Seven signals raised, the rest set aside with a reason
Signal watcherThe Signals list shows what the watcher read: 412 trial-system events, 164 registry postings, 38 regulatory updates, 655 news items, 96 ERP, 12 CRM and 71 calendar events. Seven became signals, each with its matched clause, clock and status. Events that match a clause but trigger nothing are set aside, not alerted — Corventa's China Phase 3 completing enrolment among them.
Set aside: “No payment. §5.2(b) pays US$25,000,000 on NMPA approval, not on enrolment.”
- 04One click
“Has Milestone 4 been achieved?” — six conditions tested
Trigger checkerThe trigger checker breaks the milestone into its defined elements and tests each against evidence. The event is an “Initiation” — first dose to the first subject (§1.41, trial system). TLX-301 is a “Phase 3 Clinical Trial” — the protocol v2.0 title says pivotal (§1.58). The product is a “Licensed Product” — QTX-208 (§1.44). It is the first achievement — the payment register shows Milestone 4 not invoiced or paid.
“6 of 6 conditions met” — every condition carries numbered sources, one click from the passage.
- 05The wording in force
$40M, not $35M — and Oct 20, not Nov 4
Definitions & amendment resolverAmendment No. 1, signed Mar 14, 2025, replaced §7.2(d) — $35,000,000 became $40,000,000 — and cut the §7.4 notice from 30 days to 10 Business Days. Counted on the New York bank calendar the agreement names, skipping Columbus Day on Oct 12, the 10th Business Day is Tuesday, Oct 20. Thirty days would have read Nov 4. The superseded wording stays on file, marked.
Amendment No. 1 §3: “In Section 7.4, the words ‘within thirty (30) days’ are replaced by ‘within ten (10) Business Days’.”
- 06Oct 7
She decides whether the milestone happened
Dana Okafor · Alliance directorThe checker also notes the diligence target in §5.2(b) — initiate a Phase 3 trial in a Major EU Country by Jun 30, 2027 — is met, because France counts. The decision is Dana's: confirm, ask counsel first, or record it as not achieved with a reason. Confirming fixes Oct 5, 2026 as the achievement date and starts the notice clock and the payment term.
“Confirming records Oct 5, 2026 as the achievement date … Nothing is sent until counsel signs.”
- 07Seconds later
The notice to Quillon, drafted from the clauses
Notice & report writerOnce Dana confirms, the agents act on her decision: the notice writer drafts the notice under §7.4 as amended, addressed from §15.2 to Quillon's Chief Business Officer with a copy to General Counsel (4.1 s). It states the event, the date, Study TLX-301, US$40,000,000 and the 45-day payment term in §7.6. Every statement carries a numbered citation to its source.
“Every statement cites its source — click a number.”
- 08Signed
Counsel signs with the meaning of his signature
Omar Haddad · Licensing counselThe notice goes to Omar for electronic signature. He signs as Licensing Counsel, and the notice goes out by courier and email, as the notice clause requires, with a copy filed to the agreement. The notice then reads “Signed by Omar Haddad · sent Oct 7 · copy filed to the agreement” — thirteen days inside the clock.
“Omar Haddad signs as Licensing Counsel. Meaning: I approve this notice for sending. Name, time and meaning are recorded with the document.”
- 09October close
Accrued in the month it was achieved
Finance link · Sam Patel, BD financeThe finance link drafts the October accrual (1.6 s): debit R&D expense · licence milestones (Talmirex), credit accrued liabilities · alliance milestones, $40,000,000 each way, referenced to AG-014 §7.2(d) as amended, with trial-system event 88214, protocol v2.0 and the payment register as evidence. Above $10M the controller approves before Sam posts it. Owner tasks follow: pay Quillon within 45 days of its invoice, and update the JSC by Dec 15.
“Over $10M — controller approval needed.”
- 10Oct 7 · 08:05
A partner's press release breaches a consent clause
Omar Haddad · Licensing counselNews watch matches a Marrow Point press release: Jadeport Pharma receives an exclusive sublicence to register, import and commercialise Corventa in Taiwan. Taiwan is in the licensed Territory (§2.1); a sublicence needs Northwind's prior written consent (§4.3); the consent register has no Taiwan request. Whether it is a sublicence or a distributor under §4.4 is marked a judgement, for Omar to decide by Oct 9.
Suggested: “a letter asking for the sublicence terms within 10 days, reserving Northwind’s rights under §4.3 and §14.2.”